Ralph Philip Ermoian MD, Presenter: Shareholder, Abbott Laboratories Shareholder, Abbvie Inc Shareholder, Agilent Technologies, Inc Shareholder, Allergan, Inc Shareholder, Becton, Dickinson and Company Shareholder, Boston Scientific Corporation Shareholder, Biogen Idec Inc Shareholder, Bristol-Myers Squibb Company Shareholder, Bruker Corporation Shareholder, C. R. Bard, Inc Shareholder, Dyax Corp Shareholder, Gilead Sciences, Inc Shareholder, Haemonetics Corporation Shareholder, Hospira Inc Shareholder, Illumina Inc Shareholder, McKesson Corporation Shareholder, Mylan Inc Shareholder, Myrexis, Inc Shareholder, General Electric Company Shareholder, Novartis AG Shareholder, Novo Nordisk AS Shareholder, Pfizer Inc Shareholder, Quest Diagnostics Incorporated Shareholder, Quintiles Transnational Holdings Inc Shareholder, Regeneron Pharmaceuticals, Inc Shareholder, F. Hoffmann-La Roche Ltd Shareholder, St. Jude Medical, Inc Shareholder, sanofi-aventis Group Shareholder, UnitedHealth Group Shareholder, Vertex Pharmaceuticals Incorporated Shareholder, Zimmer Holdings, Inc Shareholder, Zoetis Inc

R. Paul Guillerman MD, Presenter: Nothing to Disclose

1) Recognize the imaging findings of proton radiation therapy on different organ systems in childhood. 2) Understand how proton radiation therapy effects are influenced by the processes of growth, development, and tissue injury repair in children.

Ermoian, R, Guillerman, R, Post-radiation Therapy Pediatric Body Imaging.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002105.html